These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13808172)

  • 1. [Attempted vaccination against Candida in experimental animals].
    CASOTTI O; FRASCARELLI F
    Nuovi Ann Ig Microbiol; 1959; 10():402-9. PubMed ID: 13808172
    [No Abstract]   [Full Text] [Related]  

  • 2. Active immunization of mice against Candida albicans.
    MOURAD S; FRIEDMAN L
    Proc Soc Exp Biol Med; 1961 Mar; 106():570-2. PubMed ID: 13773272
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of serological study in superficial Candida infections].
    POSPISIL L; VLASIN Z
    Dermatologica; 1960 Apr; 120():223-30. PubMed ID: 14434388
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serology of mycotic diseases. II. Antigenic interrelations of some species of the genus Candida].
    POSPISIL L
    Zentralbl Bakteriol Orig; 1955 Aug; 163(5-6):407-9. PubMed ID: 13257687
    [No Abstract]   [Full Text] [Related]  

  • 5. Serological studies in fungi; comparison of agglutinins and precipitins in anti-candida sera.
    JONSEN J
    Acta Pathol Microbiol Scand; 1955; 37(1):79-83. PubMed ID: 14398265
    [No Abstract]   [Full Text] [Related]  

  • 6. STUDIES ON THE PATHOGENICITY OF CANDIDA IN ANIMALS.
    LEE HS
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1963 Feb; 62():116-21. PubMed ID: 14065283
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of cutaneous tests in allergy to Candida albicans].
    SCLAFER J; HEWITT J
    Pathol Biol; 1960 Feb; 8():323-7. PubMed ID: 14444172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serology and cutaneous allergy to Candida albicans. Comparative study].
    RIMBAUD P; RIOUX JA; DUNTZE F; BASTIDE JM
    Montp Med; 1961 Jan; 59():59-65. PubMed ID: 13741705
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allergy to Candida albicans].
    Charpin J; Sarbonchi J; Simon L
    Sem Hop; 1959 May; 35(21):1545-8. PubMed ID: 13659005
    [No Abstract]   [Full Text] [Related]  

  • 11. Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.
    Segal E
    Methods Mol Biol; 2017; 1625():343-353. PubMed ID: 28585001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic Genetics and Immunology of Candida Infections.
    Wang X; van de Veerdonk FL; Netea MG
    Infect Dis Clin North Am; 2016 Mar; 30(1):85-102. PubMed ID: 26897063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serological changes in rabbit blood following immunization with yeast vaccine].
    STAPANISHCHEVA ZG; REZNIKOVA LS
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Jan; 30(1):38-43. PubMed ID: 13636335
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
    Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
    J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.
    Ibrahim AS; Spellberg BJ; Avenissian V; Fu Y; Filler SG; Edwards JE
    Infect Immun; 2005 Feb; 73(2):999-1005. PubMed ID: 15664943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes.
    Segal E; Nussbaum S; Barr-Nea L
    Sabouraudia; 1985 Aug; 23(4):275-85. PubMed ID: 3901330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Recombinant Non-transmembrane Domain of Protein Mannosyltransferase 4 Improves Survival during Murine Disseminated Candidiasis.
    Wang L; Yan L; Li XX; Xu GT; An MM; Jiang YY
    Biol Pharm Bull; 2015; 38(11):1779-87. PubMed ID: 26268065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary trials in man of vaccination against Candida albicans].
    SCURO LA; PERRONE A; ZAMBONI L
    Clin Ter; 1958 May; 14(5):486-91. PubMed ID: 13561523
    [No Abstract]   [Full Text] [Related]  

  • 20. Candida parapsilosis-specific monoclonal antibodies and their use for detection of Candida antigens in experimental systemic candidiasis.
    Wong SF; Mak JW
    Hybridoma (Larchmt); 2010 Dec; 29(6):539-46. PubMed ID: 21117988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.